CLINICAL TRIALS PROFILE FOR AZELASTINE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for azelastine hydrochloride
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00561717 ↗ | A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis | Completed | Kingston General Hospital | Phase 4 | 2007-10-01 | Finding out how fast azelastine nasal spray works in subjects with hay fever. |
| NCT00561717 ↗ | A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis | Completed | Kingston Health Sciences Centre | Phase 4 | 2007-10-01 | Finding out how fast azelastine nasal spray works in subjects with hay fever. |
| NCT00561717 ↗ | A Randomized, Placebo Controlled Study to Determine the Efficacy and Speed of a Nasal Spray in Allergen Induced Seasonal Allergic Rhinitis | Completed | Bayer | Phase 4 | 2007-10-01 | Finding out how fast azelastine nasal spray works in subjects with hay fever. |
| NCT00612118 ↗ | A Phase II Study Evaluating Intranasal GSK256066 and Azelastine Hydrochloride in Subjects With Seasonal Allergic Rhinitis | Completed | GlaxoSmithKline | Phase 2 | 2008-02-01 | This study is an 8 day, randomised, double blind, 2-way crossover trial of repeat doses of intranasal GSK256066 and azelastine hydrochloride in the Vienna Challenge Chamber in subjects with seasonal allergic rhinitis (SAR). Laboratory safety assessments, 12-lead electrocardiograph (ECG), vital signs and adverse event enquiries will be made throughout the study. Nasal examination, symptom scores, and allergen challenge assessments will also be performed at various time points throughout the study. |
| NCT00651118 ↗ | A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies | Completed | Meda Pharmaceuticals | Phase 3 | 2008-03-01 | The purpose of this study is to determine if two allergy medications (azelastine and fluticasone) are more effective than placebo or either medication alone (azelastine or fluticasone) |
| NCT00660517 ↗ | A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies | Completed | Meda Pharmaceuticals | Phase 3 | 2007-12-01 | The purpose of this study is to determine if two allergy medications (azelastine and fluticasone) are more effective than placebo or either medication alone (azelastine or fluticasone) |
| NCT00660829 ↗ | A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies | Completed | Meda Pharmaceuticals | Phase 3 | 2007-12-01 | The Purpose of this study is to determine if one allergy medication (0.15% azelastine hydrochloride) is more effective than Placebo alone. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for azelastine hydrochloride
Condition Name
Clinical Trial Locations for azelastine hydrochloride
Trials by Country
Clinical Trial Progress for azelastine hydrochloride
Clinical Trial Phase
Clinical Trial Sponsors for azelastine hydrochloride
Sponsor Name
